STOCK TITAN
  1. Home
  2. KIN

Kindred Bio (KIN) Stock Price, News & Analysis

KIN NASDAQ

Company Description

Kindred Bio (NASDAQ: KIN) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for KIN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
45.5M
Shares outstanding

Latest News

View All
+45.58%

Elanco Announces Agreement to Acquire Kindred Biosciences

acquisition
+45.58%

Elanco Announces Agreement to Acquire Kindred Biosciences

acquisition
+15.99%

Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus

-4.79%

Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI

conferences
-2.93%

Kindred Biosciences Announces First Quarter 2021 Financial Results

earnings
+0.40%

Kindred Biosciences to Announce First Quarter 2021 Financial Results

earnings

Kindred Bio has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, conferences, earnings. View all KIN news →

SEC Filings

View All

No SEC filings available for KIN.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

KIN Company Profile & Sector Positioning

Kindred Bio (KIN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.